Ryan Specialty Holdings, Inc. (NYSE:RYAN - Get Free Report) shares hit a new 52-week high on Monday . The stock traded as high as $72.90 and last traded at $72.72, with a volume of 4951 shares. The stock had previously closed at $72.23.
RYAN has been the topic of a number of research reports. BMO Capital Markets raised Ryan Specialty from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $65.00 to $75.00 in a report on Tuesday, September 24th. Citigroup boosted their target price on Ryan Specialty from $56.00 to $62.00 and gave the company a "neutral" rating in a report on Tuesday, July 23rd. Keefe, Bruyette & Woods reaffirmed an "outperform" rating and set a $62.00 price target on shares of Ryan Specialty in a report on Tuesday, July 2nd. UBS Group boosted their price objective on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a "buy" rating in a research note on Tuesday, August 13th. Finally, Barclays initiated coverage on shares of Ryan Specialty in a research report on Wednesday, September 4th. They set an "overweight" rating and a $76.00 price objective for the company. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $66.78.
Check Out Our Latest Report on RYAN
The stock's 50 day moving average price is $64.87 and its two-hundred day moving average price is $58.17. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 1.81. The firm has a market capitalization of $17.96 billion, a price-to-earnings ratio of 136.28, a PEG ratio of 1.64 and a beta of 0.62.
Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its earnings results on Thursday, August 1st. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.56 by $0.02. The company had revenue of $695.40 million for the quarter, compared to analyst estimates of $695.56 million. Ryan Specialty had a net margin of 10.21% and a return on equity of 48.08%. The firm's revenue for the quarter was up 18.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.45 earnings per share. On average, analysts forecast that Ryan Specialty Holdings, Inc. will post 1.81 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, August 27th. Stockholders of record on Tuesday, August 13th were given a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date of this dividend was Tuesday, August 13th. Ryan Specialty's dividend payout ratio is currently 83.02%.
In other Ryan Specialty news, President Timothy William Turner sold 2,000,000 shares of Ryan Specialty stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $62.45, for a total value of $124,900,000.00. Following the completion of the sale, the president now owns 8,095 shares in the company, valued at $505,532.75. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction on Monday, August 19th. The shares were sold at an average price of $64.69, for a total value of $2,264,150.00. Following the completion of the sale, the director now owns 19,251 shares of the company's stock, valued at $1,245,347.19. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Timothy William Turner sold 2,000,000 shares of Ryan Specialty stock in a transaction on Friday, August 9th. The shares were sold at an average price of $62.45, for a total transaction of $124,900,000.00. Following the transaction, the president now owns 8,095 shares in the company, valued at $505,532.75. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 2,107,136 shares of company stock valued at $131,860,032 in the last quarter. 11.10% of the stock is currently owned by company insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of RYAN. Champlain Investment Partners LLC boosted its position in Ryan Specialty by 28.0% in the 1st quarter. Champlain Investment Partners LLC now owns 4,937,332 shares of the company's stock valued at $274,022,000 after buying an additional 1,079,505 shares during the last quarter. Norden Group LLC lifted its stake in shares of Ryan Specialty by 2,138.1% in the first quarter. Norden Group LLC now owns 778,848 shares of the company's stock worth $43,226,000 after acquiring an additional 744,049 shares in the last quarter. Bessemer Group Inc. boosted its holdings in Ryan Specialty by 33.9% in the first quarter. Bessemer Group Inc. now owns 1,925,864 shares of the company's stock valued at $106,886,000 after purchasing an additional 488,067 shares during the last quarter. Bank of New York Mellon Corp grew its stake in Ryan Specialty by 132.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 836,209 shares of the company's stock valued at $48,425,000 after purchasing an additional 476,126 shares in the last quarter. Finally, 2Xideas AG purchased a new stake in Ryan Specialty during the 1st quarter worth approximately $19,765,000. 84.82% of the stock is owned by institutional investors and hedge funds.
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.